Email ID
Password
Scrip   
Pharmaxis completes Topigen acquisition as antifibrotic moves forward
09 February 2010
Ian Haydock

Pharmaxis has completed its acquisition of the private Canadian firm Topigen Pharmaceuticals in a move which expands its development portfolio in the respiratory area.

The Australian company issued 3.2 million shares to seal the equity-based transaction and will issue a further five million...



Please Login to read the full article.
JOB OF THE WEEK Promote your vacancy here
© 2010 Informa plc. All rights reserved.
This site is owned and operated by Informa plc ("Informa") whose registered office is Mortimer House, 37-41 Mortimer Street, London, W1T 3JH. Registered in England and Wales. Number 3099067. UK VAT Group: GB 365 4626 36